false
OasisLMS
Login
Catalog
Kidney Week 2026 Early Program On-Demand - Critica ...
Septic Shock and AKI: How Should We Personalize MA ...
Septic Shock and AKI: How Should We Personalize MAP and Vasopressors?
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Dr. Michael Connor discussed personalizing mean arterial pressure (MAP) and vasopressor therapy in septic shock with acute kidney injury (AKI). He emphasized that blood pressure is not the same as organ perfusion: kidney blood flow can be impaired by elevated central venous or intra-abdominal pressure, even when MAP appears adequate. Measures such as MAP minus central venous pressure, abdominal perfusion pressure, capillary refill, and trends in creatinine and urine output may help identify poor perfusion, though these measures are not yet established treatment targets.<br /><br />Evidence does not support routinely targeting a higher MAP for all patients; current guidance generally favors 65–70 mmHg. However, persistent signs of hypoperfusion may justify a time-limited trial of a higher target, with close reassessment. Chronic hypertension alone does not establish a need for higher MAP. Clinicians should also reassess cardiac function as shock evolves, since impaired cardiac output can persist despite an acceptable MAP.<br /><br />For vasopressor selection, norepinephrine remains first-line, with early vasopressin often appropriate. Angiotensin II may be considered when cardiac function is adequate. If cardiac output or heart rate is insufficient, inotropic or other support may be needed. The overall approach should be guided by the patient’s perfusion, venous pressures, abdominal pressure, and cardiac function—not blood pressure alone.
Asset Caption
Michael J. Connor, MD
Meta Tag
Speaker
Michael J. Connor
Keywords
septic shock
acute kidney injury
mean arterial pressure
vasopressor therapy
norepinephrine
vasopressin
organ perfusion
kidney blood flow
×
Please select your language
1
English